Phase 2 Readout~quarter
Phase 2 Readout: pali-2108
- Company
- PALISADE BIO, INC. (PALI)
- Drug
- pali-2108
- Indication
- Ulcerative Colitis (UC)
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Get real-time alerts, AI-powered analysis, and full catalyst coverage.